COST-EFFECTIVENESS OF ANTI-BCMA CAR T-CELL THERAPY IN TRIPLE-CLASS REFRACTORY MULTIPLE MYELOMA

被引：0
|
作者：
Barnes, J., I [1 ]
Frosch, Z. A. [2 ]
Garfall, A. L. [3 ]
Vogl, D. [3 ]
Lin, J. [3 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[3] Univ Penn, Philadelphia, PA 19104 USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE41
引用
收藏
页码：S343 / S343
页数：1
相关论文
共 50 条
  • [41] Comprehensive meta-analysis of anti-BCMA chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma
    Zhang, Lina
    Shen, Xuxing
    Yu, Wenjun
    Li, Jing
    Zhang, Jue
    Zhang, Run
    Li, Jianyong
    Chen, Lijuan
    ANNALS OF MEDICINE, 2021, 53 (01) : 1547 - 1559
  • [42] Patterns of Relapse and Clinical Outcomes in Multiple Myeloma Patients after Anti-BCMA CAR T-Cell Therapy: Implications for Patient's Monitoring after CAR T-Cell Therapy
    Puglianini, Omar Alexis Castaneda
    Peres, Lauren C.
    Hansen, Doris K.
    Nishihori, Taiga
    Grajales-Cruz, Ariel F.
    Blue, Brandon J.
    Brayer, Jason
    Freeman, Ciara L.
    Shain, Kenneth H.
    Liu, Hien D.
    Ochoa, Jose
    Locke, Frederick L.
    Baz, Rachid C.
    Alsina, Melissa
    BLOOD, 2022, 140 : 7538 - 7539
  • [43] Risk Factors Associated with Durable Progression-Free Survival in Patients with Relapsed or Refractory Multiple Myeloma Treated with Anti-BCMA CAR T-cell Therapy
    Zhang, Mingming
    Zhou, Linghui
    Zhao, Houli
    Zhang, Yanlei
    Wei, Guoqing
    Hong, Ruimin
    Wu, Wenjun
    Xu, Huijun
    Wang, Linqin
    Ni, Fang
    Cui, Jiazhen
    Peng, Shuixiu
    Huang, Chih-Hua
    Chang, Alex H.
    Hu, Yongxian
    Huang, He
    CLINICAL CANCER RESEARCH, 2021, 27 (23) : 6384 - 6392
  • [44] Efficacy and safety of commercially approved BCMAtargeting CAR-T therapy in triple-class refractory multiple myeloma
    Nishimura, Noriko
    Brown, Samantha
    Sean, M. Devlin
    Parastoo, Dahi
    Heather, J. Landau
    Oscar, B. Lahoud
    Michael, Scordo
    Gunjan, L. Shah
    David, J. Chung
    Hani, Hassoun
    Malin, Hultcrantz
    Neha, Korde
    Alexander, M. Lesokhin
    Sham, Mailankody
    Urvi, A. Shah
    Carlyn, R. Tan
    Saad, Z. Usmani
    Giralt, Sergio A.
    ANNALS OF ONCOLOGY, 2023, 34 : S1427 - S1428
  • [45] CT053, Anti-BCMA CAR T-cell therapy for Relapsed/Refractory Multiple Myeloma: Proof of Concept results from a Phase I Study
    Hao, Siguo
    Jin, Jie
    Yu, Kang
    Li, Zonghai
    Zhang, Wenhao
    Yang, Min
    Jiang, Songfu
    Chen, Peishuai
    Ma, Liyuan
    Meng, Haitao
    He, Mingxia
    Wang, Wei
    Chen, Linjun
    Huang, Xin
    Xing, Chongyun
    Yuan, Daijing
    Tao, Rong
    Wang, Shasha
    Dai, Lihui
    Ma, Hong
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E54 - E55
  • [46] A combination of humanized anti-BCMA and murine anti-CD38 CAR-T cell therapy in patients with relapsed or refractory multiple myeloma
    Zhang, Huan
    Liu, Man
    Xiao, Xia
    Lv, Hairong
    Jiang, Yanyu
    Li, Xin
    Yuan, Ting
    Zhao, Mingfeng
    LEUKEMIA & LYMPHOMA, 2022, 63 (06) : 1418 - 1427
  • [47] BCMA CAR T-cell therapy arrives for multiple myeloma: a reality
    Cho, Shih-Feng
    Anderson, Kenneth C.
    Tai, Yu-Tzu
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6
  • [48] BCMA-directed CAR T-cell therapy in multiple myeloma
    Cookson, Emma
    LANCET HAEMATOLOGY, 2020, 7 (07): : E505 - E505
  • [49] In vivo expansion patterns of anti-BCMA CAR T-cell in relapsed/refractory multiple myeloma: Comparative immunomonitoring of idecabtagene vicleucel and ciltacabtagene autoleucel
    Kocoglu, Mehmet
    Rapoport, Aaron P.
    Gebru, Etse
    Omili, Destiny
    Yamoah, Daniel
    Mulatu, Rediet
    Yared, Jean
    Hardy, Nancy M.
    Kallen, Michael
    Badros, Ashraf Z.
    Atanackovic, Djordje
    CANCER RESEARCH, 2024, 84 (06)
  • [50] Patterns of Failure in Multiple Myeloma with Extramedullary Disease Following Anti-BCMA Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Nakashima, J. Y.
    Khatri, V.
    Cruz-Chamorro, R. J.
    Zhou, J.
    Patra, P.
    Gonzalez, R.
    De Avila, G.
    Locke, F. L.
    Liu, H. D.
    Nishihori, T.
    Puglianini, O. C.
    Alsina, M.
    Garjales-Cruz, A.
    Baz, R.
    Shah, B. D.
    Shain, K.
    Jain, M. D.
    Hansen, D.
    Freeman, C.
    Figura, N. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S206 - S207
12345